TY  - JOUR
AU  - Morata, L
AU  - Cobo, J
AU  - Fernández-Sampedro, M
AU  - Guisado Vasco, P
AU  - Ruano, E
AU  - Lora-Tamayo, J
AU  - Sánchez Somolinos, M
AU  - González Ruano, P
AU  - Rico Nieto, A
AU  - Arnaiz, A
AU  - Estébanez Muñoz, M
AU  - Jiménez-Mejías, M E
AU  - Lozano Serrano, A B
AU  - Múñez, E
AU  - Rodriguez-Pardo, D
AU  - Argelich, R
AU  - Arroyo, A
AU  - Barbero, J M
AU  - Cuadra, F
AU  - Del Arco, A
AU  - Del Toro, M D
AU  - Guio, L
AU  - Jimenez-Beatty, D
AU  - Lois, N
AU  - Martin, O
AU  - Martínez Alvarez, R M
AU  - Martinez-Marcos, F J
AU  - Porras, L
AU  - Ramírez, M
AU  - Vergas García, J
AU  - Soriano, A
PY  - 2019
DO  - 10.1128/AAC.02280-18
UR  - http://hdl.handle.net/10668/13687
T2  - Antimicrobial agents and chemotherapy
AB  - Dalbavancin is a lipoglycopeptide with potent activity against Gram-positive microorganisms, a long half-life, a favorable safety profile, and a high concentration in bone, which makes it an interesting alternative for treatment of osteoarticular...
LA  - en
KW  - bone and joint infections
KW  - dalbavancin
KW  - osteomyelitis
KW  - prosthetic joint infection
KW  - Aged
KW  - Bone and Bones
KW  - Female
KW  - Gram-Positive Bacteria
KW  - Humans
KW  - Joints
KW  - Male
KW  - Microbial Sensitivity Tests
KW  - Middle Aged
KW  - Osteomyelitis
KW  - Staphylococcus aureus
KW  - Staphylococcus epidermidis
KW  - Teicoplanin
TI  - Safety and Efficacy of Prolonged Use of Dalbavancin in Bone and Joint Infections.
TY  - research article
VL  - 63
ER  -